(4bR,6R,7R,8aS)-4b-benzyl-6,7-dihydroxy-6-methyl-N-(2-methylpyridin-3-yl)-10-oxo-7-phenyl-4b,5,6,7,8,8a,9,10-octahydrophenanthrene-2-carboxamide | 1206876-95-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 菲及其衍生物
• 英文名称: (4bR,6R,7R,8aS)-4b-benzyl-6,7-dihydroxy-6-methyl-N-(2-methylpyridin-3-yl)-10-oxo-7-phenyl-4b,5,6,7,8,8a,9,10-octahydrophenanthrene-2-carboxamide
• 英文别名: 2-Phenanthrenecarboxamide, 4b,5,6,7,8,8a,9,10-octahydro-6,7-dihydroxy-6-methyl-N-(2-methyl-3-pyridinyl)-10-oxo-7-phenyl-4b-(phenylmethyl)-, (4bR,6R,7R,8aS)-；(4bR,6R,7R,8aS)-4b-benzyl-6,7-dihydroxy-6-methyl-N-(2-methylpyridin-3-yl)-10-oxo-7-phenyl-5,8,8a,9-tetrahydrophenanthrene-2-carboxamide
• CAS: 1206876-95-0
• 化学式: C₃₅H₃₄N₂O₄
• 分子量: 546.666
• InChiKey: GZOXYYZSDATUNP-WHQVQTAISA-N

物化性质

• 沸点：
  686.4±55.0 °C(Predicted)
• 密度：
  1.297±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  41
• 可旋转键数：
  5
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  99.5
• 氢给体数：
  3
• 氢受体数：
  5

制备方法与用途

PF-04308515 (also known as PF 4308515) is a potent glucocorticoid receptor (GR) agonist that exhibits strong anti-inflammatory activity.

反应信息

• 作为产物：
  描述：

  (4bR,6R,7R,8aR)-4b-benzyl-6,7-dihydroxy-6-methyl-N-(2-methylpyridin-3-yl)-7-phenyl-4b,5,6,7,8,8a,9,10-octahydrophenanthrene-2-carboxamide 在 盐酸 、 臭氧 、 二甲基硫 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 以79%的产率得到(4bR,6R,7R,8aS)-4b-benzyl-6,7-dihydroxy-6-methyl-N-(2-methylpyridin-3-yl)-10-oxo-7-phenyl-4b,5,6,7,8,8a,9,10-octahydrophenanthrene-2-carboxamide
  参考文献：
  名称：

  [EN] PHENANTHRENONE COMPOUNDS, COMPOSITIONS AND METHODS
  [FR] COMPOSÉS DE PHÉNANTHRÉNONE, COMPOSITIONS ET PROCÉDÉS

  摘要：

  本发明涉及化合物的公式（I）或其盐，这些化合物是糖皮质激素受体的调节剂。本发明的化合物和盐在治疗由糖皮质激素受体活性介导的疾病方面具有用途。

  公开号：

  WO2010013158A1

文献信息

• PHENATHRENONE COMPOUNDS, COMPOSITONS AND METHODS
  申请人：Rucker Paul V.

  公开号：US20100069444A1

  公开（公告）日：2010-03-18

  The present invention is directed to compounds of Formula I: or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.

  本发明涉及式I的化合物：或其盐，它们是糖皮质激素受体的调节剂。本发明的化合物和盐在治疗由糖皮质激素受体活性介导的疾病方面是有用的。
• PHENANTHRENONE COMPOUNDS, COMPOSITIONS AND METHODS
  申请人：RUCKER Paul V.

  公开号：US20120157502A1

  公开（公告）日：2012-06-21

  The present invention is directed to compounds of Formula I: or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.

  本发明涉及公式I的化合物：或其盐，它们是糖皮质激素受体的调节剂。本发明的化合物和盐在治疗由糖皮质激素受体活性介导的疾病方面是有用的。
• Phenathrenone compounds, compositons and methods
  申请人：Pfizer Inc.

  公开号：US08148409B2

  公开（公告）日：2012-04-03

  The present invention is directed to compounds of Formula I: or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.

  本发明涉及公式I的化合物或其盐，它们是糖皮质激素受体的调节剂。本发明的化合物和盐在治疗由糖皮质激素受体活性介导的病症方面是有用的。
• Phenanthrenone compounds, compositions and methods
  申请人：Rucker Paul V.

  公开号：US08552035B2

  公开（公告）日：2013-10-08

  The present invention is directed to compounds of Formula I: or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.

  本发明涉及I式化合物：或其盐，其为糖皮质激素受体调节剂。本发明的化合物和盐在治疗由糖皮质激素受体活性介导的疾病方面有用。
• US8148409B2
  申请人：——

  公开号：US8148409B2

  公开（公告）日：2012-04-03